Fellström B, Lindsjö M, Danielson B G, Karlsson F A, Ljunghall S
Department of Internal Medicine, University Hospital, Uppsala, Sweden.
Clin Chim Acta. 1989 Apr 14;180(3):213-220. doi: 10.1016/0009-8981(89)90002-8.
Several inhibitors of calcium oxalate crystallization have been identified and shown to exhibit quantitative and qualitative differences in efficacy. Glycosaminoglycans are potent inhibitors of crystal growth and aggregation, and the efficiency seems to increase with an increasing charge density. In order to investigate the mechanism of inhibition, we performed binding experiments of radioactivity labelled heparin, chondroitin sulphate and the low-molecular mass heparin analogue pentosan polysulphate to calcium oxalate crystals and subsequent displacements by increasing the amounts of non-radioactive ligands or increasing ionic strength. Ligands with a high charge density bound more readily and with a seemingly higher affinity than ligands with a low charge density, but were also more susceptible to displacement when the ionic strength was increased. It is concluded that a higher affinity to the crystals may be the reason why highly charged glycosaminoglycans are more efficient inhibitors of calcium oxalate crystal growth.
几种草酸钙结晶抑制剂已被鉴定出来,并显示出在功效上存在定量和定性差异。糖胺聚糖是晶体生长和聚集的有效抑制剂,其效率似乎随着电荷密度的增加而提高。为了研究抑制机制,我们进行了放射性标记的肝素、硫酸软骨素和低分子质量肝素类似物戊聚糖多硫酸盐与草酸钙晶体的结合实验,随后通过增加非放射性配体的量或增加离子强度进行置换。电荷密度高的配体比电荷密度低的配体更容易结合,且似乎具有更高的亲和力,但当离子强度增加时,它们也更容易被置换。得出的结论是,对晶体具有更高的亲和力可能是高电荷糖胺聚糖是更有效的草酸钙晶体生长抑制剂的原因。